基于人类胎盘体外循环灌注模型探讨艾司西酞普兰的胎盘透过性

姚勤; 王晶晶; 李骞; 王思捷; 黄桦; 柳汝明; 张峻

doi:10.14009/j.issn.1672-2124.2022.11.005

您当前的位置：

首页 >

文章列表页 >

基于人类胎盘体外循环灌注模型探讨艾司西酞普兰的胎盘透过性

论著 | 更新时间：2023-04-16

- 基于人类胎盘体外循环灌注模型探讨艾司西酞普兰的胎盘透过性
- Placental Permeability of Escitalopram Based on Human Placental Extracorporeal Circulation Perfusion Model
- 中国医院用药评价与分析 2022年第11期页码：1306-1309
- 作者机构：
  
  昆明医科大学第一附属医院临床药学科
- 作者简介：
- 基金信息：
  
  云南省卫生和计划生育委员会医学人才培养计划项目（No.L-201614,No.D-2018043,No.H-2017051,No.H-2018081）;云南省教育厅科学研究基金项目（No.2019J1237）;云南省基础研究计划—昆医联合专项项目（No.2019FE001-208）
- DOI：10.14009/j.issn.1672-2124.2022.11.005
  中图分类号： R971.4
- 纸质出版日期：2022，
扫描看全文
姚勤, 王晶晶, 李骞, 等. 基于人类胎盘体外循环灌注模型探讨艾司西酞普兰的胎盘透过性[J]. 中国医院用药评价与分析, 2022,(11):1306-1309.

YAO Qin, WANG Jingjing, LI Qian, et al. Placental Permeability of Escitalopram Based on Human Placental Extracorporeal Circulation Perfusion Model[J]. 2022,(11):1306-1309.
姚勤, 王晶晶, 李骞, 等. 基于人类胎盘体外循环灌注模型探讨艾司西酞普兰的胎盘透过性[J]. 中国医院用药评价与分析, 2022,(11):1306-1309. DOI： 10.14009/j.issn.1672-2124.2022.11.005.

YAO Qin, WANG Jingjing, LI Qian, et al. Placental Permeability of Escitalopram Based on Human Placental Extracorporeal Circulation Perfusion Model[J]. 2022,(11):1306-1309. DOI： 10.14009/j.issn.1672-2124.2022.11.005.

摘要

目的：应用人胎盘体外循环灌注模型，对艾司西酞普兰进行胎盘透过性研究。方法：选择刚娩出的健康足月人胎盘，建立胎盘体外循环灌注模型，循环灌注3 h

期间从母体池和子体池取样，检测pH、氧分压、β-人绒毛膜促性腺激素、葡萄糖消耗量、乳酸生成量、子体池液体损耗量以及阳性对照物安替比林和艾司西酞普兰的浓度以评估其胎盘透过率。结果：本研究共进行了158例人类胎盘体外循环灌注模型的建立，符合模型建立成功标准的有15例。3 h循环灌注后，艾司西酞普兰胎盘透过率为（9.09±2.80）%

相对透过率为（23.35±4.37）%。结论：艾司西酞普兰可少量透过胎盘而导致胎儿暴露于艾司西酞普兰中。

Abstract

OBJECTIVE: To probe into the placental permeability of escitalopram by human placental extracorporeal circulation perfusion model. METHODS: Healthy and full-term human placentas that had just been delivered were selected

the placental extracorporeal circulation perfusion model was established and circularly perfused for 3 h. During this period

samples were taken from the maternal pool and the fetal pool

and the pH

β-human chorionic gonadotropin

glucose consumption

lactate production

fluid loss from the fetal pool

the concentrations of positive controls of antipyrine and escitalopram were detected to assess the placental transmission rates. RESULTS: In this study

158 human placental extracorporeal circulation perfusion models were performed

and 15 cases met the criteria for successful model establishment. After 3 h of circulation perfusion

the placental permeation rate of escitalopram was（9.09±2.80）% and the relative permeation rate was（23.35±4.37）%. CONCLUSIONS: Escitalopram can penetrate the placenta in small dose and lead to fetal exposure to escitalopram.

关键词

艾司西酞普兰胎盘转运体外人胎盘灌注模型

Keywords

EscitalopramPlacental transferExtracorporeal human placental circulation perfusion

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

多塞平联合艾司西酞普兰对抑郁症患者胶质细胞源性神经营养因子、5-羟色胺水平的影响

艾司西酞普兰血药浓度/剂量比的影响因素研究

坦索罗辛联合艾司西酞普兰治疗慢性非细菌性前列腺炎伴焦虑抑郁的临床研究

艾司西酞普兰联合多巴丝肼治疗帕金森病的临床效果及对炎症因子的影响